Immune checkpoint inhibitors may variably impact patients with pre-existing autoimmune diseases.

Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases / Meserve, Joseph; Facciorusso, Antonio; Holmer, Ariela K; Annese, Vito; Sandborn, William J; Singh, Siddharth. - In: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. - ISSN 1365-2036. - 53:3(2020), pp. 374-382. [10.1111/apt.16217]

Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases

Annese, Vito;
2020-01-01

Abstract

Immune checkpoint inhibitors may variably impact patients with pre-existing autoimmune diseases.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/147797
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 50
  • ???jsp.display-item.citation.isi??? 50
social impact